Cargando…
Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases
Allergic bronchopulmonary aspergillosis (ABPA) is an eosinophilic pulmonary disorder caused by a hypersensitivity reaction to Aspergillus fumigatus that manifests with uncontrolled asthma, peripheral blood eosinophilia, and radiological findings, such as mucus plugging. Early diagnosis and proper tr...
Autores principales: | Tolebeyan, Amirseena, Mohammadi, Oranus, Vaezi, Zahra, Amini, Afshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486017/ https://www.ncbi.nlm.nih.gov/pubmed/32923277 http://dx.doi.org/10.7759/cureus.9684 |
Ejemplares similares
-
Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
por: Hamada, Toru, et al.
Publicado: (2023) -
A Case of Allergic Bronchopulmonary Aspergillosis With Bronchial Asthma
por: Rajpopat, Pratik Bharat, et al.
Publicado: (2022) -
Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab
por: Mikura, Sunao, et al.
Publicado: (2021) -
A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab
por: Terashima, Takeshi, et al.
Publicado: (2018) -
Mepolizumab use in cystic fibrosis‐associated allergic bronchopulmonary aspergillosis
por: Boyle, Maeve, et al.
Publicado: (2020)